Business
Short Term Estimates And Forecasts For Cardiff Oncology Inc (CRDF)
Cardiff Oncology Inc (NASDAQ:CRDF) has a beta value of 1.56 and has seen 0.45 million shares traded in the recent trading session. The company, currently
Cardiff Oncology Inc (NASDAQ:CRDF) has a beta value of 1.56 and has seen 0.45 million shares traded in the recent trading session. The company, currently
During the last session, Cardiff Oncology Inc (NASDAQ:CRDF)’s traded shares were 0.66 million, with the beta value of the company hitting 1.56. At the end
© 2024, Powered by Smart TechOne